Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins

Clinical Rheumatology

Volumn 16, Issue 3, 1997, Pages 275-278

  Lacki, J K ^a,b   Samborski, W ^a   Mackiewicz, S H ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Department of Rheumatology ^*  (Poland)

Author keywords

Acute Phase Proteins; Interleukin 10; Interleukin 6; Rheumatoid Arthritis; Systemic Lupus Erythematosus

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GOLD SALT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; OROSOMUCOID; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOREGULATION; INTRAVENOUS DRUG ADMINISTRATION; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACUTE-PHASE PROTEINS; ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 0030982298     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02238963     Document Type: Article

References (23)

1. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-8.
2. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J immunol 1991; 147: 3815-22.
3. Moore KW, O'Garra A, de Waal-Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165-90.
4. Bogdan C, Vodovotz Y, Nathan C. Macrophage deactivation by interleukin 10. J Exp Med 1991; 174: 1549-55.
5. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-IO acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-51.
6. Howard M, O'Garra A. Biological properties of interleukin-10. Immunol Today 1992; 13: 198-200.
7. Mallya RK, De Beer FC, Berry H. Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of CRP and ESR. J Rheumatol 1982; 9: 224-8.
8. Mackiewicz A, Pawlowski T, Mackiewicz-Pawlowska A, Wiktorowicz K, Mackiewicz S. Microheterogeneity of alpha-1-acid glycoprotein as indicator of rheumatoid arthritis activity. Clin Chim Acta 1987; 163: 185-90.
9. Gabay C, Roux-Lombard P, de Moerloose P, Dayer JM, Vischer T, Guerne PA. Absence of correlation between interleukin-6 and Creactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993; 20: 815-21.
10. Swaak AJG, van Rooyen A, Aarden LA. IL-6 and acute phase proteins in the disease course of patients with SLE. Rheumatol Int 1989; 8: 263-8.
11. Hirano T, Akira S, Taga T, Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol Today 1991; 11: 443-9.
12. Tan EM, Cohen AS, Fries JF, Masi AT, AcShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
13. Arnet FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
14. Klinman MK, Steinberg AD. Inquiry into murine and human lupus. Immunol Rev 1995; 144: 157-93.
15. Miltenburg AMM, Van Laar JM, De Kniper R, Daha MR, Breedveld FC. T cell clones from human rheumatoid synovial membrane functionally represent the th1 subset. Scand J Immunol 1992; 35: 603-9.
16. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldman M. Immunoregulatory role of interleukin-10 in rheumatoid arthritis. J Exp Med 1994; 179: 1517-27.
17. Llorente L, Richaud-Patin Y, Wijdenes J. Spontaneous production of IL-10 by B lymphocytes in SLE. Eur Cytokine Netw 1993; 4:421-30.
18. Llorente L, Richaud-Patin Y, Fior R. In vivo production of IL-10 by non-T cells in RA, Sjögren syndrome, and SLE. Arthritis Rheum 1994; 37: 1647-55.
19. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147: 117-23.
20. Sugiyama E, Kuroda A, Hori F, Hori T, Taki H, Arai N, Kobayashi M. Serum interleukin-6 level is a sensitive parameter of disease activity in RA. J Clin Rheumatol 1995; 1: 93-8.
21. Baumann H, Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein gens as interleukin-6. J Biol Chem 1991; 266: 20424-7.
22. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro. J Immunol 1992; 148: 1731-6.
23. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-Jphn S. Ciliary neutrophic factor induces APP expression in hepatocytes. FEBS lett 1992; 314: 280-4.